• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环中的 Dickkopf-1、骨保护素和硬化蛋白水平在老年人中高于年轻人,并且与老年人的全身骨矿物质密度呈正相关。

Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.

机构信息

School of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.

Baylor College of Medicine, Houston, TX, USA.

出版信息

Osteoporos Int. 2017 Sep;28(9):2683-2689. doi: 10.1007/s00198-017-4104-2. Epub 2017 Jun 5.

DOI:10.1007/s00198-017-4104-2
PMID:28585053
Abstract

UNLABELLED

Bone mineral density declines with increasing older age. We examined the levels of circulating factors known to regulate bone metabolism in healthy young and older adults. The circulating levels of dickkopf-1, osteocalcin, osteoprotegerin and sclerostin were positively associated with whole-body bone mineral density (WBMD) in older adults, despite the average WBMD being lower and circulating dickkopf-1, osteoprotegerin and sclerostin being higher in old than young.

INTRODUCTION

This study aims to investigate the relationship between whole-body bone mineral density (WBMD) and levels of circulating factors with known roles in bone remodelling during 'healthy' ageing.

METHODS

WBMD and fasting plasma concentrations of dickkopf-1, fibroblast growth factor-23, osteocalcin, osteoprotegerin, osteopontin and sclerostin were measured in 272 older subjects (69 to 81 years; 52% female) and 171 younger subjects (18-30 years; 53% female).

RESULTS

WBMD was lower in old than young. Circulating osteocalcin was lower in old compared with young, while dickkopf-1, osteoprotegerin and sclerostin were higher in old compared with young. These circulating factors were each positively associated with WBMD in the older adults and the relationships remained after adjustment for covariates (r values ranging from 0.174 to 0.254, all p < 0.01). In multivariate regression, the body mass index, circulating sclerostin and whole-body lean mass together accounted for 13.8% of the variation with WBMD in the older adults. In young adults, dickkopf-1 and body mass index together accounted for 7.7% of variation in WBMD.

CONCLUSION

Circulating levels of dickkopf-1, osteocalcin, osteoprotegerin and sclerostin are positively associated with WBMD in community-dwelling older adults, despite the average WBMD being lower and circulating dickkopf-1, osteoprotegerin and sclerostin being higher in old than young.

摘要

未加标签

骨密度随年龄增长而下降。我们检查了已知调节骨代谢的循环因子水平在健康的年轻和老年成年人中。循环骨钙素、骨保护素和硬化素水平与老年人的全身骨密度(WBMD)呈正相关,尽管老年人的平均 WBMD 较低,循环骨钙素、骨保护素和硬化素水平较高。

引言

本研究旨在探讨全身骨密度(WBMD)与已知在“健康”衰老过程中具有骨重塑作用的循环因子水平之间的关系。

方法

在 272 名老年受试者(69-81 岁;52%为女性)和 171 名年轻受试者(18-30 岁;53%为女性)中测量了 WBMD 和空腹血浆中 dickkopf-1、成纤维细胞生长因子 23、骨钙素、骨保护素、骨桥蛋白和硬化素的浓度。

结果

WBMD 在老年人中低于年轻人。与年轻人相比,老年人的循环骨钙素水平较低,而 dickkopf-1、骨保护素和硬化素水平较高。这些循环因子在老年人中均与 WBMD 呈正相关,并且在调整协变量后,这些关系仍然存在(r 值范围为 0.174 至 0.254,所有 p 值均<0.01)。在多元回归中,体质指数、循环硬化素和全身瘦体重共同解释了老年人 WBMD 变异的 13.8%。在年轻成年人中,dickkopf-1 和体质指数共同解释了 WBMD 变异的 7.7%。

结论

尽管老年人的平均 WBMD 较低,循环 dickkopf-1、骨保护素和硬化素水平较高,但循环 dickkopf-1、骨钙素、骨保护素和硬化素水平与社区居住的老年成年人的 WBMD 呈正相关。

相似文献

1
Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.循环中的 Dickkopf-1、骨保护素和硬化蛋白水平在老年人中高于年轻人,并且与老年人的全身骨矿物质密度呈正相关。
Osteoporos Int. 2017 Sep;28(9):2683-2689. doi: 10.1007/s00198-017-4104-2. Epub 2017 Jun 5.
2
Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.瑞典75岁及以上新发髋部骨折老年患者与健康对照者血清中骨转换标志物Dickkopf-1、硬化蛋白、骨保护素、骨桥蛋白、骨钙素和25-羟基维生素D的水平。
J Endocrinol Invest. 2016 Aug;39(8):855-63. doi: 10.1007/s40618-015-0421-5. Epub 2016 Feb 5.
3
Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.Dickkopf-1 水平升高表明 Wnt/β-连环蛋白下调和 1 型糖尿病患儿和青少年成骨细胞信号转导降低,导致骨密度降低。
Osteoporos Int. 2017 Mar;28(3):945-953. doi: 10.1007/s00198-016-3802-5. Epub 2016 Oct 20.
4
Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.库欣综合征患者血清中经典 Wnt/β-连环蛋白信号通路的细胞外分泌拮抗剂。
Osteoporos Int. 2013 Aug;24(8):2191-9. doi: 10.1007/s00198-013-2268-y. Epub 2013 Jan 29.
5
Association between osteocalcin and cognitive performance in healthy older adults.健康老年人中骨钙素与认知表现之间的关联。
Age Ageing. 2016 Nov;45(6):844-849. doi: 10.1093/ageing/afw137. Epub 2016 Aug 11.
6
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis.青少年特发性关节炎高活动度成年患者的血清硬化蛋白
Arthritis Res Ther. 2014 Oct 4;16(5):460. doi: 10.1186/s13075-014-0460-x.
7
Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.硬化蛋白血浆水平降低而非Dickkopf-1与绝经后韩国女性骨质疏松性骨折患病率增加及骨密度降低有关。
Calcif Tissue Int. 2016 Oct;99(4):350-9. doi: 10.1007/s00223-016-0160-4. Epub 2016 Jun 11.
8
Circulating sclerostin associated with vertebral bone marrow fat in older men but not women.循环骨硬化蛋白与老年男性而非女性的椎骨髓脂肪有关。
J Clin Endocrinol Metab. 2014 Dec;99(12):E2584-90. doi: 10.1210/jc.2013-4493.
9
Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.脊柱后纵韧带骨化中循环骨硬化蛋白和 Dickkopf-1 水平
J Bone Miner Metab. 2016 May;34(3):315-24. doi: 10.1007/s00774-015-0671-5. Epub 2015 Jun 4.
10
Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer.芳香酶抑制剂对乳腺癌患者血清骨硬化蛋白和 Dickkopf-1、骨转换标志物及骨密度的影响。
J Cancer Res Clin Oncol. 2014 Oct;140(10):1671-80. doi: 10.1007/s00432-014-1726-z. Epub 2014 Jun 7.

引用本文的文献

1
Regulatory cellular and molecular networks in the bone microenvironment during aging.衰老过程中骨微环境中的调节性细胞和分子网络。
Life Med. 2024 May 2;3(3):lnae019. doi: 10.1093/lifemedi/lnae019. eCollection 2024 Jun.
2
Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly.硬化蛋白和骨保护素/核因子κB受体活化因子配体系统参与肢端肥大症患者的骨重塑过程。
Front Endocrinol (Lausanne). 2024 Dec 17;15:1472680. doi: 10.3389/fendo.2024.1472680. eCollection 2024.
3
Exploring the Role of Hormones and Cytokines in Osteoporosis Development.

本文引用的文献

1
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α.双膦酸盐治疗与未治疗的成骨不全儿童的骨重塑受损:DKK1、RANKL和TNF-α的作用
Osteoporos Int. 2016 Jul;27(7):2355-2365. doi: 10.1007/s00198-016-3501-2. Epub 2016 Feb 8.
2
Functional diversity of fibroblast growth factors in bone formation.成纤维细胞生长因子在骨形成中的功能多样性
Int J Endocrinol. 2015;2015:729352. doi: 10.1155/2015/729352. Epub 2015 Mar 19.
3
Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths.
探索激素和细胞因子在骨质疏松症发展中的作用。
Biomedicines. 2024 Aug 12;12(8):1830. doi: 10.3390/biomedicines12081830.
4
Albumin-to-alkaline phosphatase ratio may be a better predictor of survival than sclerostin, dickkopf-1, osteopontin, osteoprotegerin and osteocalcin.与硬化素、Dickkopf-1、骨桥蛋白、骨保护素和骨钙素相比,白蛋白与碱性磷酸酶的比值可能是更好的生存预测指标。
Heliyon. 2024 Apr 12;10(8):e29639. doi: 10.1016/j.heliyon.2024.e29639. eCollection 2024 Apr 30.
5
Sex Differences in Bone, Muscle, and Inflammatory Markers and Their Associations with Muscle Performance Variables.骨骼、肌肉及炎症标志物的性别差异及其与肌肉性能变量的关联
Sports (Basel). 2023 Nov 6;11(11):215. doi: 10.3390/sports11110215.
6
Effects of an Intervention with Selenium and Coenzyme Q on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial.补充硒和辅酶 Q10 对低硒瑞典老年人 5 种与年龄相关生物标志物的影响:指向抗衰老作用的结果——一项先前前瞻性双盲安慰剂对照随机临床试验的亚分析。
Cells. 2023 Jul 4;12(13):1773. doi: 10.3390/cells12131773.
7
Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration.考虑硬化蛋白浓度时肌肉质量和力量对骨矿化的影响
Biomedicines. 2023 May 29;11(6):1574. doi: 10.3390/biomedicines11061574.
8
The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.慢性肾脏病-矿物质和骨异常综合征中的 WNT/β-连环蛋白系统。
Int Urol Nephrol. 2023 Oct;55(10):2527-2538. doi: 10.1007/s11255-023-03569-2. Epub 2023 Mar 24.
9
Serum concentrations of osteoprotegerin, brain-derived nerve factor, angiotensin II, and endothelin-1 in aging dogs.衰老犬血清骨保护素、脑源性神经营养因子、血管紧张素 II 和内皮素-1 浓度。
Open Vet J. 2022 Nov-Dec;12(6):980-984. doi: 10.5455/OVJ.2022.v12.i6.26. Epub 2022 Dec 15.
10
Differential Expression of Dickkopf 1 and Periostin in Mouse Strains with High and Low Bone Mass.Dickkopf 1和骨膜蛋白在高骨量和低骨量小鼠品系中的差异表达
Biology (Basel). 2022 Dec 16;11(12):1840. doi: 10.3390/biology11121840.
硬化蛋白和 Dickkopf-1(DKK-1):HIV 感染青少年骨代谢的两个重要调节因子。
Endocrine. 2015 Aug;49(3):783-90. doi: 10.1007/s12020-015-0527-8. Epub 2015 Jan 18.
4
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.炎性细胞因子、RANKL/OPG轴及免疫骨骼界面在生理性骨转换和骨质疏松症中的作用
Scientifica (Cairo). 2013;2013:125705. doi: 10.1155/2013/125705. Epub 2013 Feb 3.
5
Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.年龄对人类骨组织中 Sclerostin 及其他与骨代谢相关基因的 mRNA 水平的影响。
Bone. 2014 Feb;59:1-6. doi: 10.1016/j.bone.2013.10.019. Epub 2013 Oct 29.
6
Physiological and functional evaluation of healthy young and older men and women: design of the European MyoAge study.健康青年男女和老年男女的生理和功能评估:欧洲 MyoAge 研究的设计。
Biogerontology. 2013 Jun;14(3):325-37. doi: 10.1007/s10522-013-9434-7. Epub 2013 May 31.
7
Sclerostin and bone strength in women in their 10th decade of life.绝经后 10 年女性的骨强度与骨硬化蛋白。
J Bone Miner Res. 2013 Sep;28(9):2008-16. doi: 10.1002/jbmr.1929.
8
Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study.男性骨微结构参数与血清硬化素水平的相关性:STRAMBO 研究。
J Bone Miner Res. 2013 Aug;28(8):1760-70. doi: 10.1002/jbmr.1888.
9
Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.骨疾病中骨硬化蛋白和 Dickkopf-1 作为治疗靶点。
Endocr Rev. 2012 Oct;33(5):747-83. doi: 10.1210/er.2011-1060. Epub 2012 Jun 20.
10
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.绝经后妇女血清硬骨素与骨密度、骨转换、类固醇和甲状旁腺激素及骨折风险的关系:OFELY 研究。
Osteoporos Int. 2013 Feb;24(2):489-94. doi: 10.1007/s00198-012-1978-x. Epub 2012 Apr 14.